Kevin C. Tang, Chief Executive Officer, 10% Owner, Officer, Chief Financial Officer at Odonate Therapeutics, Inc. (ODT), bought 45,620 shares at $18.72 ($863K) on 2018-08-13, disclosed to the SEC on 2018-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.72 | 6,791 | $127K | 14.7% |
| 2 | $18.72 | 6,791 | $127K | 14.7% |
| 3 | $18.98 | 6,603 | $125K | 14.5% |
| 4 | $18.98 | 6,603 | $125K | 14.5% |
| 5 | $18.86 | 2,810 | $53K | 6.1% |
| 6 | $18.86 | 2,810 |
| $53K |
| 6.1% |
| 7 | $19.11 | 6,606 | $126K | 14.6% |
| 8 | $19.11 | 6,606 | $126K | 14.6% |
| Total | $18.93 avg | 45,620 | $863K | 100% |
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |